 | • レポートコード：GIR201106212 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療機器 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、変形性関節症疼痛の世界市場を調査対象にし、変形性関節症疼痛の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（経口、非経口）、用途別分析（病院、薬局、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Abbott Laboratories、Astellas Pharma、Pfizer、Johnson & Johnson、Afferent Pharmaceuticals、Novartis International、Crystal Genomics、Abiogen Pharma、AbbVie、BioDelivery Sciences International、Cytori Therapeutics ・メーカー別販売量、売上、市場シェア ・変形性関節症疼痛の地域別市場分析 ・変形性関節症疼痛の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・変形性関節症疼痛のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・変形性関節症疼痛のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・変形性関節症疼痛の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・変形性関節症疼痛の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・変形性関節症疼痛の種類別市場規模2015-2020：経口、非経口 ・変形性関節症疼痛の用途別市場規模2015-2020：病院、薬局、その他 ・変形性関節症疼痛の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Osteoarthritis Pain market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Osteoarthritis Pain market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Osteoarthritis Pain market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Osteoarthritis Pain market has been segmented into
Oral
Non-Oral
By Application, Osteoarthritis Pain has been segmented into:
Hospital
Pharmacy
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Osteoarthritis Pain market presented in the report. This section sheds light on the sales growth of different regional and country-level Osteoarthritis Pain markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Osteoarthritis Pain market.
The report offers in-depth assessment of the growth and other aspects of the Osteoarthritis Pain market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Osteoarthritis Pain Market Share Analysis
Osteoarthritis Pain competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Osteoarthritis Pain sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Osteoarthritis Pain sales, revenue and market share for each player covered in this report.
The major players covered in Osteoarthritis Pain are:
Abbott Laboratories
Astellas Pharma
Pfizer
Johnson & Johnson
Afferent Pharmaceuticals
Novartis International
Crystal Genomics
Abiogen Pharma
AbbVie
BioDelivery Sciences International
Cytori Therapeutics
Among other players domestic and global, Osteoarthritis Pain market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Osteoarthritis Pain product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Osteoarthritis Pain, with price, sales, revenue and global market share of Osteoarthritis Pain in 2018 and 2019.
Chapter 3, the Osteoarthritis Pain competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Osteoarthritis Pain breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Osteoarthritis Pain market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Osteoarthritis Pain sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Osteoarthritis Pain Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Osteoarthritis Pain Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Oral
1.2.3 Non-Oral
1.3 Market Analysis by Application
1.3.1 Overview: Global Osteoarthritis Pain Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Overview of Global Osteoarthritis Pain Market
1.4.1 Global Osteoarthritis Pain Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Astellas Pharma
2.2.1 Astellas Pharma Details
2.2.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Astellas Pharma SWOT Analysis
2.2.4 Astellas Pharma Product and Services
2.2.5 Astellas Pharma Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson & Johnson SWOT Analysis
2.4.4 Johnson & Johnson Product and Services
2.4.5 Johnson & Johnson Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Afferent Pharmaceuticals
2.5.1 Afferent Pharmaceuticals Details
2.5.2 Afferent Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Afferent Pharmaceuticals SWOT Analysis
2.5.4 Afferent Pharmaceuticals Product and Services
2.5.5 Afferent Pharmaceuticals Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis International
2.6.1 Novartis International Details
2.6.2 Novartis International Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis International SWOT Analysis
2.6.4 Novartis International Product and Services
2.6.5 Novartis International Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Crystal Genomics
2.7.1 Crystal Genomics Details
2.7.2 Crystal Genomics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Crystal Genomics SWOT Analysis
2.7.4 Crystal Genomics Product and Services
2.7.5 Crystal Genomics Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Abiogen Pharma
2.8.1 Abiogen Pharma Details
2.8.2 Abiogen Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Abiogen Pharma SWOT Analysis
2.8.4 Abiogen Pharma Product and Services
2.8.5 Abiogen Pharma Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 AbbVie
2.9.1 AbbVie Details
2.9.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 AbbVie SWOT Analysis
2.9.4 AbbVie Product and Services
2.9.5 AbbVie Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 BioDelivery Sciences International
2.10.1 BioDelivery Sciences International Details
2.10.2 BioDelivery Sciences International Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 BioDelivery Sciences International SWOT Analysis
2.10.4 BioDelivery Sciences International Product and Services
2.10.5 BioDelivery Sciences International Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Cytori Therapeutics
2.11.1 Cytori Therapeutics Details
2.11.2 Cytori Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Cytori Therapeutics SWOT Analysis
2.11.4 Cytori Therapeutics Product and Services
2.11.5 Cytori Therapeutics Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Osteoarthritis Pain Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Osteoarthritis Pain Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Osteoarthritis Pain Manufacturer Market Share in 2019
3.3.2 Top 6 Osteoarthritis Pain Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Osteoarthritis Pain Sales, Revenue and Market Share by Regions
4.1.1 Global Osteoarthritis Pain Sales and Market Share by Regions (2015-2020)
4.1.2 Global Osteoarthritis Pain Revenue and Market Share by Regions (2015-2020)
4.2 North America Osteoarthritis Pain Sales and Growth Rate (2015-2020)
4.3 Europe Osteoarthritis Pain Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Osteoarthritis Pain Sales and Growth Rate (2015-2020)
4.5 South America Osteoarthritis Pain Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Osteoarthritis Pain Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Osteoarthritis Pain Sales, Revenue and Market Share by Country
5.1.1 North America Osteoarthritis Pain Sales and Market Share by Country (2015-2020)
5.1.2 North America Osteoarthritis Pain Revenue and Market Share by Country (2015-2020)
5.2 United States Osteoarthritis Pain Sales and Growth Rate (2015-2020)
5.3 Canada Osteoarthritis Pain Sales and Growth Rate (2015-2020)
5.4 Mexico Osteoarthritis Pain Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Osteoarthritis Pain Sales, Revenue and Market Share by Country
6.1.1 Europe Osteoarthritis Pain Sales and Market Share by Country (2015-2020)
6.1.2 Europe Osteoarthritis Pain Revenue and Market Share by Country (2015-2020)
6.2 Germany Osteoarthritis Pain Sales and Growth Rate (2015-2020)
6.3 UK Osteoarthritis Pain Sales and Growth Rate (2015-2020)
6.4 France Osteoarthritis Pain Sales and Growth Rate (2015-2020)
6.5 Russia Osteoarthritis Pain Sales and Growth Rate (2015-2020)
6.6 Italy Osteoarthritis Pain Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Osteoarthritis Pain Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Osteoarthritis Pain Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Osteoarthritis Pain Revenue and Market Share by Regions (2015-2020)
7.2 China Osteoarthritis Pain Sales and Growth Rate (2015-2020)
7.3 Japan Osteoarthritis Pain Sales and Growth Rate (2015-2020)
7.4 Korea Osteoarthritis Pain Sales and Growth Rate (2015-2020)
7.5 India Osteoarthritis Pain Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Osteoarthritis Pain Sales and Growth Rate (2015-2020)
7.7 Australia Osteoarthritis Pain Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Osteoarthritis Pain Sales, Revenue and Market Share by Country
8.1.1 South America Osteoarthritis Pain Sales and Market Share by Country (2015-2020)
8.1.2 South America Osteoarthritis Pain Revenue and Market Share by Country (2015-2020)
8.2 Brazil Osteoarthritis Pain Sales and Growth Rate (2015-2020)
8.3 Argentina Osteoarthritis Pain Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Osteoarthritis Pain Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Osteoarthritis Pain Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Osteoarthritis Pain Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Osteoarthritis Pain Sales and Growth Rate (2015-2020)
9.3 Turkey Osteoarthritis Pain Sales and Growth Rate (2015-2020)
9.4 Egypt Osteoarthritis Pain Sales and Growth Rate (2015-2020)
9.5 South Africa Osteoarthritis Pain Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Osteoarthritis Pain Sales and Market Share by Type (2015-2020)
10.2 Global Osteoarthritis Pain Revenue and Market Share by Type (2015-2020)
10.3 Global Osteoarthritis Pain Price by Type (2015-2020)
11 Global Osteoarthritis Pain Market Segment by Application
11.1 Global Osteoarthritis Pain Sales Market Share by Application (2015-2020)
11.2 Global Osteoarthritis Pain Revenue Market Share by Application (2015-2020)
11.3 Global Osteoarthritis Pain Price by Application (2015-2020)
12 Market Forecast
12.1 Global Osteoarthritis Pain Sales, Revenue and Growth Rate (2021-2025)
12.2 Osteoarthritis Pain Market Forecast by Regions (2021-2025)
12.2.1 North America Osteoarthritis Pain Market Forecast (2021-2025)
12.2.2 Europe Osteoarthritis Pain Market Forecast (2021-2025)
12.2.3 Asia-Pacific Osteoarthritis Pain Market Forecast (2021-2025)
12.2.4 South America Osteoarthritis Pain Market Forecast (2021-2025)
12.2.5 Middle East & Africa Osteoarthritis Pain Market Forecast (2021-2025)
12.3 Osteoarthritis Pain Market Forecast by Type (2021-2025)
12.3.1 Global Osteoarthritis Pain Sales Forecast by Type (2021-2025)
12.3.2 Global Osteoarthritis Pain Market Share Forecast by Type (2021-2025)
12.4 Osteoarthritis Pain Market Forecast by Application (2021-2025)
12.4.1 Global Osteoarthritis Pain Sales Forecast by Application (2021-2025)
12.4.2 Global Osteoarthritis Pain Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Osteoarthritis Pain Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Osteoarthritis Pain by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Osteoarthritis Pain Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Laboratories Osteoarthritis Pain Major Business
Table 9. Abbott Laboratories Osteoarthritis Pain Total Revenue (USD Million) (2018-2019)
Table 10. Abbott Laboratories SWOT Analysis
Table 11. Abbott Laboratories Osteoarthritis Pain Product and Services
Table 12. Abbott Laboratories Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Astellas Pharma Osteoarthritis Pain Major Business
Table 15. Astellas Pharma Osteoarthritis Pain Total Revenue (USD Million) (2018-2019)
Table 16. Astellas Pharma SWOT Analysis
Table 17. Astellas Pharma Osteoarthritis Pain Product and Services
Table 18. Astellas Pharma Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Osteoarthritis Pain Major Business
Table 21. Pfizer Osteoarthritis Pain Total Revenue (USD Million) (2018-2019)
Table 22. Pfizer SWOT Analysis
Table 23. Pfizer Osteoarthritis Pain Product and Services
Table 24. Pfizer Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 26. Johnson & Johnson Osteoarthritis Pain Major Business
Table 27. Johnson & Johnson Osteoarthritis Pain Total Revenue (USD Million) (2018-2019)
Table 28. Johnson & Johnson SWOT Analysis
Table 29. Johnson & Johnson Osteoarthritis Pain Product and Services
Table 30. Johnson & Johnson Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Afferent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Afferent Pharmaceuticals Osteoarthritis Pain Major Business
Table 33. Afferent Pharmaceuticals Osteoarthritis Pain Total Revenue (USD Million) (2018-2019)
Table 34. Afferent Pharmaceuticals SWOT Analysis
Table 35. Afferent Pharmaceuticals Osteoarthritis Pain Product and Services
Table 36. Afferent Pharmaceuticals Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Novartis International Basic Information, Manufacturing Base and Competitors
Table 38. Novartis International Osteoarthritis Pain Major Business
Table 39. Novartis International Osteoarthritis Pain Total Revenue (USD Million) (2018-2019)
Table 40. Novartis International SWOT Analysis
Table 41. Novartis International Osteoarthritis Pain Product and Services
Table 42. Novartis International Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Crystal Genomics Basic Information, Manufacturing Base and Competitors
Table 44. Crystal Genomics Osteoarthritis Pain Major Business
Table 45. Crystal Genomics Osteoarthritis Pain Total Revenue (USD Million) (2018-2019)
Table 46. Crystal Genomics SWOT Analysis
Table 47. Crystal Genomics Osteoarthritis Pain Product and Services
Table 48. Crystal Genomics Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Abiogen Pharma Basic Information, Manufacturing Base and Competitors
Table 50. Abiogen Pharma Osteoarthritis Pain Major Business
Table 51. Abiogen Pharma Osteoarthritis Pain Total Revenue (USD Million) (2018-2019)
Table 52. Abiogen Pharma SWOT Analysis
Table 53. Abiogen Pharma Osteoarthritis Pain Product and Services
Table 54. Abiogen Pharma Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. AbbVie Basic Information, Manufacturing Base and Competitors
Table 56. AbbVie Osteoarthritis Pain Major Business
Table 57. AbbVie Osteoarthritis Pain Total Revenue (USD Million) (2018-2019)
Table 58. AbbVie SWOT Analysis
Table 59. AbbVie Osteoarthritis Pain Product and Services
Table 60. AbbVie Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. BioDelivery Sciences International Basic Information, Manufacturing Base and Competitors
Table 62. BioDelivery Sciences International Osteoarthritis Pain Major Business
Table 63. BioDelivery Sciences International Osteoarthritis Pain Total Revenue (USD Million) (2018-2019)
Table 64. BioDelivery Sciences International SWOT Analysis
Table 65. BioDelivery Sciences International Osteoarthritis Pain Product and Services
Table 66. BioDelivery Sciences International Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Cytori Therapeutics Basic Information, Manufacturing Base and Competitors
Table 68. Cytori Therapeutics Osteoarthritis Pain Major Business
Table 69. Cytori Therapeutics Osteoarthritis Pain Total Revenue (USD Million) (2018-2019)
Table 70. Cytori Therapeutics SWOT Analysis
Table 71. Cytori Therapeutics Osteoarthritis Pain Product and Services
Table 72. Cytori Therapeutics Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Osteoarthritis Pain Sales by Manufacturer (2018-2019) (K Units)
Table 74. Global Osteoarthritis Pain Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Osteoarthritis Pain Sales by Regions (2015-2020) (K Units)
Table 76. Global Osteoarthritis Pain Sales Market Share by Regions (2015-2020)
Table 77. Global Osteoarthritis Pain Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Osteoarthritis Pain Sales by Countries (2015-2020) (K Units)
Table 79. North America Osteoarthritis Pain Sales Market Share by Countries (2015-2020)
Table 80. North America Osteoarthritis Pain Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Osteoarthritis Pain Revenue Market Share by Countries (2015-2020)
Table 82. Europe Osteoarthritis Pain Sales by Countries (2015-2020) (K Units)
Table 83. Europe Osteoarthritis Pain Sales Market Share by Countries (2015-2020)
Table 84. Europe Osteoarthritis Pain Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Osteoarthritis Pain Sales by Regions (2015-2020) (K Units)
Table 86. Asia-Pacific Osteoarthritis Pain Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Osteoarthritis Pain Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Osteoarthritis Pain Sales by Countries (2015-2020) (K Units)
Table 89. South America Osteoarthritis Pain Sales Market Share by Countries (2015-2020)
Table 90. South America Osteoarthritis Pain Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Osteoarthritis Pain Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Osteoarthritis Pain Sales by Countries (2015-2020) (K Units)
Table 93. Middle East & Africa Osteoarthritis Pain Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Osteoarthritis Pain Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Osteoarthritis Pain Revenue Market Share by Countries (2015-2020)
Table 96. Global Osteoarthritis Pain Sales by Type (2015-2020) (K Units)
Table 97. Global Osteoarthritis Pain Sales Share by Type (2015-2020)
Table 98. Global Osteoarthritis Pain Revenue by Type (2015-2020) (USD Million)
Table 99. Global Osteoarthritis Pain Revenue Share by Type (2015-2020)
Table 100. Global Osteoarthritis Pain Sales by Application (2015-2020) (K Units)
Table 101. Global Osteoarthritis Pain Sales Share by Application (2015-2020)
Table 102. Global Osteoarthritis Pain Sales Forecast by Regions (2021-2025) (K Units)
Table 103. Global Osteoarthritis Pain Market Share Forecast by Regions (2021-2025)
Table 104. Global Osteoarthritis Pain Sales Forecast by Type (2021-2025) (K Units)
Table 105. Global Osteoarthritis Pain Market Share Forecast by Type (2021-2025)
Table 106. Global Osteoarthritis Pain Sales Forecast by Application (2021-2025)
Table 107. Global Osteoarthritis Pain Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Osteoarthritis Pain Picture
Figure 2. Global Sales Market Share of Osteoarthritis Pain by Type in 2019
Figure 3. Oral Picture
Figure 4. Non-Oral Picture
Figure 5. Osteoarthritis Pain Sales Market Share by Application in 2018
Figure 6. Hospital Picture
Figure 7. Pharmacy Picture
Figure 8. Other Picture
Figure 9. Global Osteoarthritis Pain Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Osteoarthritis Pain Sales Market Share by Manufacturer in 2019
Figure 30. Global Osteoarthritis Pain Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Osteoarthritis Pain Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Osteoarthritis Pain Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Osteoarthritis Pain Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Osteoarthritis Pain Revenue Market Share by Regions (2015-2020)
Figure 37. Global Osteoarthritis Pain Revenue Market Share by Regions in 2018
Figure 38. North America Osteoarthritis Pain Sales and Growth Rate (2015-2020)
Figure 39. Europe Osteoarthritis Pain Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Osteoarthritis Pain Sales and Growth Rate (2015-2020)
Figure 41. South America Osteoarthritis Pain Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Osteoarthritis Pain Sales and Growth Rate (2015-2020)
Figure 43. North America Osteoarthritis Pain Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Osteoarthritis Pain Sales Market Share by Countries (2015-2020)
Figure 45. North America Osteoarthritis Pain Sales Market Share by Countries in 2018
Figure 46. North America Osteoarthritis Pain Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Osteoarthritis Pain Revenue Market Share by Countries in 2018
Figure 48. United States Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Osteoarthritis Pain Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Osteoarthritis Pain Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Osteoarthritis Pain Revenue Market Share by Countries in 2019
Figure 54. Germany Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Osteoarthritis Pain Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Osteoarthritis Pain Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Osteoarthritis Pain Revenue Market Share by Regions 2019
Figure 62. China Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Osteoarthritis Pain Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Osteoarthritis Pain Sales Market Share by Countries in 2019
Figure 69. South America Osteoarthritis Pain Revenue Market Share by Countries in 2019
Figure 70. Brazil Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Osteoarthritis Pain Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Osteoarthritis Pain Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Osteoarthritis Pain Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Osteoarthritis Pain Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Osteoarthritis Pain Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Osteoarthritis Pain Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Osteoarthritis Pain Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Osteoarthritis Pain Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Osteoarthritis Pain Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Osteoarthritis Pain Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Osteoarthritis Pain Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
変形性関節症鎮痛剤の世界市場 2020年 Market Overview The Osteoarthritis Pain Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…- 変形性関節症苦痛治療薬の世界市場 2020年 Market Overview The Drugs for Osteoarthritis Pain market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 変形性関節症用栄養・サプリメントの世界市場 2020年 Market Overview The Osteoarthritis Nutrition and Food Supplements market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, v…
- 変形性膝関節症治療の世界市場 2020年 Market Overview The Knee Osteoarthritis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- OTC鎮痛薬の世界市場 2020年 Market Overview The global OTC Pain Medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The OTC Pain Medications mar…